Introduction: White matter hyperintense (WMHI) lesions are the most common finding in magnetic resonance imaging (MRI) of the brain in patients with systemic lupus erythematosus (SLE). Objective: The objective of this article is to determine the clinical factors associated with an increase in WMHI lesion load among SLE patients. Method: A total of 83 SLE patients with MRI of the brain from National University of Malaysia Medical Centre were included. The WMHI lesion load was determined using the Scheltens score and Fazekas scale, and their distribution was divided into the deep white matter (DWMHI) and periventricular (PVH) regions. The clinical correlates of WMHI lesions were initially determined using univariate analyses and subsequently multivariable regression analyses were performed to determine the independent factors of increased WMHI lesion load. Results: MRI of the brain of 46 patients who had WMHI lesions were compared with 37 patients with normal MRI. We found significant association between the presence of WMHI lesions and age, presence of cerebral infarcts, positive antiphospholipid antibody (aPL), active disease, neuropsychiatric lupus (NPSLE) and disease damage. Age, SLEDAI scores, cerebral infarcts and disease damage were significantly associated with higher DWMHI and PVH Scheltens scores. Meanwhile, patients with active lupus nephritis (LN), lower serum albumin and more severe proteinuria were associated with larger Fazekas WMHI lesions. Multivariable regression analysis revealed that the independent factors associated with presence of WMHI lesions were positive aPL and SLEDAI scores (p < 0.05). Higher WMHI Scheltens scores in both DWMHI and PVH were associated with presence of cerebral infarct but higher PVH lesion load was significantly associated with active SLE disease. Conclusion: Presence of WMHI lesions in SLE was significantly associated with cerebral infarcts, aPL and high general SLE activity, suggesting both inflammation and ischaemia as the underlying pathology of these lesions. Lupus (2018) 27, 25-32.
Introduction
Magnetic resonance imaging (MRI) remains the most important neuroimaging tool in diagnostic work-up for systemic lupus erythematosus (SLE) patients with neurological manifestations. White matter hyperintensity (WMHI) lesions are striking abnormalities that are often found on T2-weighted and fluid-attenuated inversion recovery (FLAIR) images in lupus patients. These lesions have been reported to be present in up to 70% of SLE patients. 1 Despite being the most prevalent MRI finding, they are often non-specific as these lesions may occur without underlying neuropsychiatric lupus (NPSLE). 2, 3 WMHI lesions are divided into two classes depending on their location: deep and periventricular WMHI. Deep white matter lesions (DWMHI) are located at the end and border zones of arterial perfusion of the white matter. Meanwhile, periventricular white matter lesions (PVH) are located near the ventricular ependyma, particularly at the anterior and posterior horns of the lateral ventricles. Both of these lesions have different underlying aetiologies as DWMHI are believed to be primarily driven by arterial ischaemia and are strongly correlated with vascular risk factors. On the other hand, the association between PVH and vascular risk factors is weaker 4 as they can be non-ischaemic in origin, which include periventricular venous collagenosis, and ependymal leakage due to endothelial dysfunction. 4, 5 The exact pathology of these non-necrotic hyperintensity or non-specific WMHI lesions in SLE is largely unknown as the majority of histopathological studies involved mainly patients with NPSLE symptoms only. However, it is likely that the presence of WMHI lesions in SLE are multifactorial as the white matter lesions can be produced by small-vessel angiopathy related to endothelial dysfunction, 6 vasculitis, 7 microthromboemboli 8 and demyelination. 9 Histopathologically, these lesions represent areas of gliosis, 10 demyelination 11 and loss of axons. 5 In patients with SLE, the clinical significance of the presence of incidental non-necrotic WMHI lesions is still unclear but various studies have shown that these lesions are associated with fatigue, 12 headache, cognitive impairment, seizures, and Raynaud's phenomenon. 13 Positive antiphospholipid antibodies (aPL) [14] [15] [16] and hypertension 13 were also reported to be significantly associated with WMH lesions.
There have been only a few studies which involved patients with isolated white matter lesions 13 and several other studies included patients with various other cerebral pathologies 17 or patients with NPSLE only. 18 Therefore, this study was performed to determine the various associated factors of increase WMHI lesions among our multiracial Asian lupus cohort.
Methodology

SLE patients
Consecutive SLE patients who had brain MRI at the National University of Malaysia Medical Centre (UKMMC) from June 2007 until June 2016 were reviewed. All patients fulfilled the revised American College Rheumatology (ACR) 1997 criteria for SLE. 19 The MRI protocol included sagittal T1-weighted, axial T1-weighted, axial T2-weighted, coronal fluid-attenuated inversion recovery (FLAIR) sequences, followed by diffusionweighted imaging (DWI). In these individuals, T2-weighted and FLAIR images were screened for the presence of WMHI lesions, which were defined as areas with increased signal intensity in the white matter on T2 and FLAIR sequences. These lesions were generally ill defined, small, had no cavitations and could not be related to any types of pathology such as mass effects, other than non-specific WMHI. 20, 21 The WMHI lesions were differentiated from acute infarcts by the presence of diffusion restriction in the DWI in the latter condition. 22 Apart from that, presence of old infarcts were distinguished from WMHI lesions by having more distinct, sharp margins, rounded shape, and high signal on T2 but reduced signal centrally on FLAIR, indicating a cerebrospinal fluid (CSF)-containing cavity. 23 This study was approved by the Research Ethics Committee, National University of Malaysia (FF-2016-436) .
SLE patients with normal brain MRI were included into the study as controls. Subsequently the visual and semi-quantitative rating of the WMHI lesions were performed. All MRI scans were read by an experienced neuroradiologist who was blinded to the demographic or clinical data.
Visual and semi-quantitative rating of WMHI lesions
Assessments of the WMHI lesions' severity were performed using the semi-quantitative visual rating of the Scheltens score 24 and Fazekas scale, 25 which are frequently used in research. Both scales have been validated histopathologically 5, 26 and have good agreement with quantitative volumetric measurements. 27 The total numbers on the WMHI lesions were traced on T2 proton density (PD)-weighted images and they were evaluated using Scheltens score in four regions: (1) the periventricular region (PV), (2) the subcortical and deep white matter of the frontal, parietal, temporal and occipital areas (FPTOs), (3) the basal ganglia (BG) and (4) the infratentorial region (IT). 24 The total score for the PVH lesions ranged from 0 to 9, for the DWMHI lesions from 0 to 24, for basal ganglia WMHI lesions ranged from 0 to 30, and for infratentorial ranged from 0 to 24. The total WMHI lesions score for the Scheltens scale for each participant thus ranged from 0 to 84, with a higher score indicating a larger amount of total WMHI lesions.
With the brain MRI with FLAIR sequences, we applied the visual rating scales of Fazekas of the WMHI lesions in two regions: (1) the periventricular area and (2) white matter area. These lesions were graded from 0 to 3, depending on size and confluence of the lesions as below. 25 (1) PVH 0 ¼ absent 1 ¼ ''caps'' or pencil-thin lining 2 ¼ smooth ''halo'' 3 ¼ irregular periventricular signal extending into the deep white matter (2) DWMHI 0 ¼ absent 1 ¼ punctate foci 2 ¼ beginning confluence 3 ¼ large confluent areas All ratings were performed by an experienced neuroradiologist who was blinded to the patients' clinical data.
SLE disease characteristics
The disease characteristics (disease duration and organ or system involvement) during the time of the brain MRI scans were obtained from the medical records. Active neuropsychiatric involvement at the time of MRI imaging was defined according to the ACR nomenclature and case definitions for NPSLE. 29 Presence of aPL was defined as either lupus anticoagulant positive and/or anticardiolipin antibody (aCL) titre of more than 20 GPL, and/or B2 glycoprotein-I positive. Presence of comorbidities, e.g. cardiovascular disease, diabetes mellitus, hypertension and hyperlipidaemia, were also recorded.
Disease activity and disease damage assessment
Disease activity during the MRI was measured using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). 29 The index has been validated and shown to be reliable and sensitive to changes in disease activity in SLE. [30] [31] [32] It includes 24 clinical features and laboratory variables from different organs or system involvement, e.g. renal, haematological, neuropsychiatric, mucocutaneous, musculoskeletal, serositis, vasculitis and fever. These variables are weighted by the type of manifestations and disease activity scores may range from 0 to 105. 29 Patients with SLEDAI score !4 were categorized into the active disease group. 33 Cumulative SLE-related damage at the time of MRI was determined by the Systemic Lupus International Collaborating Clinics/ACR (SLICC/ ACR) Disease Damage index. 34 It was developed and validated to measure accumulated organ damage from either the disease process or its sequelae, in 12 organ systems. 34 Patients were categorized into presence of damage if the score was 1 or more (SDI ! 1), and absence of damage if the score was 0 (SDI ¼ 0).
Statistical analysis
All normally distributed numerical data were expressed as mean AE SD and non-normally distributed data were expressed as median AE interquartile range (IQR). Comparisons were made between SLE patients with presence of WMHI lesions and without WMHI lesions. Subsequently, statistical analyses were performed to determine the associated factors of an increase in WMHI lesions assessed by Scheltens scores and Fazekas classification. Group differences among subject characteristics and associated factors were tested for statistical significance using the t-test or analysis of variance (ANOVA) (for normally distributed continuous data), Mann-Whitney U test (for non-normally distributed continuous data) and 2 test (categorical data). Bivariate Pearson (for normally distributed continuous data) and Spearman (for non-normally distributed data) were performed to determine the factors which correlated with the number of WMHI Scheltens scores. Significance was taken as p 0.05.
Multivariable binary logistic regression analysis was performed to determine the odds ratio of each independent predictor of presence of WMHI lesions in SLE patients. In the binary logistic regression analysis, all factors which were found to be associated with presence of WMHI in the univariate analyses with p < 0.01 were included.
Subsequently, multiple regression analyses (stepwise method) were used to determine the independent factors which were correlated with the Scheltens scores of DWMHI, PVH and total WMHI lesions. All variables in the univariate analyses were included in the multiple regression analyses.
Due to the small sample size in each category of the Fazekas scale, we did not proceed to any multivariate analysis. All statistical analyses were performed using the SPSS program version 18.0.
Results
A total of 88 patients were identified to have MRI brain performed from June 2007 until June 2016. However, two of them were excluded due to MRI finding of brain abscess and tuberculoma. Meanwhile three of the patients were excluded in White matter lesions in SLE SS Shaharir et al.
view of the inability to retrieve the MRI images from the electronic medical records. Ultimately a total of 83 patients were includ into the study and 46 (55.4%) of them had WMHI lesions. The average age at the time when the MRI was performed was 35.9 AE 12.3 years and more than half of them were Malays (n ¼ 53, 63.9%) followed by Chinese (n ¼ 25, 30.1%) and Indians (n ¼ 5, 6.1%). More than half of the cohort had haematological manifestations (n ¼ 55, 66.3%), followed by musculoskeletal (n ¼ 54, 65.9%), LN (n ¼ 37, 45.1%), mucocutaneous (n ¼ 36, 43.9%), NPSLE (n ¼ 36, 43.9%) and serositis (n ¼ 8, 9.8%).
The main reason for the MRI brain to be performed was investigation of headache (n ¼ 32, 38.5%), followed by visual disturbances (n ¼ 12, 14.6%), seizure or epilepsy (n ¼ 11, 13.3%), psychosis (n ¼ 5, 6.1%), cognitive dysfunction (n ¼ 5, 6.1%), investigation for limb weakness (n ¼ 5, 6.1%), cerebrovascular accidents (n ¼ 3, 3.7%), mood disorders (n ¼ 2, 2.4%), cranial neuropathy (n ¼ 2, 2.4%), acute confusional state (n ¼ 2,2.4%), abnormal movement/dyskinesia (n ¼ 1, 1.2%), transient global amnesia (n ¼ 1, 1.2%), facial numbness (n ¼ 1, 1.2%) and transverse myelitis (n ¼ 1, 1.2%). Twenty-six patients (31.7%) had hypertension, 23 (28%) had dyslipidaemia while only two of them (2.4%) had steroid-induced diabetes mellitus. Two patients were ex-smokers (2.4%) and no patients in this lupus cohort had underlying cardiovascular disease.
Presence of WMHI lesions was significantly associated with higher age, positive aPL, presence of disease damage, higher SLEDAI score, NPSLE, and presence of cerebral infarcts (all p < 0.05). Table 1 illustrates the demographic and disease characteristics between SLE patients with and without WMHI lesions.
Pearson's correlation analyses revealed that there were significant correlations between total DWMHI, PVH and WMHI Scheltens scores with age, SLEDAI scores, presence of cerebral infarcts, and disease damage ( Table 2) .
Further analysis of the size and shape of DWMHI and PVH lesions using the Fazekas scale revealed that presence of disease damage, active LN with more severe proteinuria (higher urine protein-creatinine index (PCI)), and higher SLEDAI scores were associated with higher Fazekas grades of DWMHI and PVH. Age was associated only with higher DWMHI Fazekas scale but not with PVH. Tables 3 and 4 compare the clinical characteristics of SLE patients with Fazekas scales of the DWMHI and PVH.
Multivariable logistic regression analysis revealed that only positive aPL and SLEDAI scores were the significant independent associated factors with the WMHI in SLE (Table 5) 
Discussion
WMHI lesions on T2 and FLAIR brain MRI are very common and can be found in up to 60% in patients with SLE, especially in the fronto-parietel Increasing age has been demonstrated to be associated with the presence of WMHI lesions in general populations [39] [40] [41] and SLE patients. 13, 37 Our study demonstrated that age was no longer an independent factor associated with the presence of WMHI lesions in the multivariable logistic regression analysis and it was not significantly correlated with the WMHI lesion load in the DWMHI and PVH regions. This finding further supports the notion that WMHI lesions in SLE may have different pathogenesis as positive aPL and higher SLEDAI scores were the factors strongly associated with the presence of WMHI lesions among our SLE cohort.
Since the hallmark pathophysiology of SLE is secondary to autoantibody-mediated inflammation, generalized active lupus may lead to generalized vascular inflammation and endothelial dysfunction, which in turn can produce the white matter changes seen on MRI. There was also a postulation that a subclinical central nervous system (CNS) involvement may occur in SLE patients who have no overt neuropsychiatric symptoms. 18 Despite a higher prevalence of NPSLE patients with WMHI lesions, the associations between them were weak as it was no longer found to be significant in multivariable regression analysis. Therefore, presence of WMHI is not specific for NPSLE as it has been demonstrated by other studies to also occur in non-NPSLE patients. 42, 43 Nonetheless, our study demonstrated that presence of NPSLE was significantly associated with larger Fazekas scales of WMHI lesions both in DWMHI and PVH regions and this is in keeping with many other previous studies which reported a higher volume of WMHI lesions among NPSLE patients. 13, 43, 44 aPL have long been recognized to be one of the risk factors of vasculopathy in SLE. 45 Thus many other studies have demonstrated a significant association between positive aPL with WMHI [14] [15] [16] and it was postulated that these lesions are related to thromboembolism or small-vessel injury promoted by the presence of aPL. Since WMHI also represents microvascular disease, it is not surprising that the presence of these lesions were significantly associated with the presence of cerebral infarcts both in univariate and multivariate analyses.
The association between presence of cerebral infarcts and the WMHI lesion burden both in DWMHI and PVH regions was in agreement with the concept of a shared underlying pathogenesis of these two lesions, which involved small-vessel ischaemia. 46 Interestingly, our study also demonstrated that SLE patients with active disease had a higher WMHI lesion load at the PVH regions (total PVH Scheltens scores), rather than at the DWMHI regions. This phenomenon again raises the question of the existence of a distinct pathogenesis involved in the development of the hyperintense lesions in the DWMHI and PVH regions as described earlier. Indeed, an earlier post-mortem study found that the typical pathology of PVH lesions were oedema related to blood-barrier disruption, 47 which is the hallmark of SLE activity. In this study, we also demonstrated that SLE patients with active LN who had a more severe degree of proteinuria or higher urine PCI and hypoalbuminaemia were also associated with higher grade of DWMHI and PVH lesions. Indeed, many other studies have demonstrated that proteinuria indicates a generalized endothelial dysfunction 48 which may lead to the leakage of fluid into the white matter, and among the general population, microalbuminuria was shown to be associated with WMHI lesions in hypertensive patients 49 and elderly individuals. Presence of disease damage was also found to be associated with higher grades of DWMHI and PVH lesions and this finding concurred with other previous studies which showed a similar observation. This study has several limitations due to the retrospective design and the small number of participants. Apart from that, since the MRIs were performed for patients with neurological symptoms, selection bias was inevitable and therefore the findings may not be representative of other general SLE cohorts. Therefore, larger prospective studies are needed in the future. Nevertheless, to our knowledge, our study is the first to use semiquantitative scoring of WMHI lesion load to determine the associated factors of such lesions in a multi-ethnic Asian SLE cohort.
In summary, our study demonstrated that WMHI lesions in SLE could be linked to ischaemic or occlusive vascular disease as they were significantly associated with presence of cerebral infarct and presence of aPL. Apart from that, WMHI lesions may represent active inflammation as they were significantly associated with high general SLE activity.
